[Federal Register Volume 84, Number 201 (Thursday, October 17, 2019)]
[Notices]
[Pages 55575-55576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22683]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-N-3263]
Request for Nominations of a Nonvoting Representative of the
Interest of the Tobacco Manufacturing Industry on the Tobacco Products
Scientific Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is requesting
nominations for a nonvoting representative of the interests of the
tobacco manufacturing industry to serve on the Tobacco Products
Scientific Advisory Committee (TPSAC), in the Center for Tobacco
Products. FDA seeks to include the views of women and men, members of
all racial and ethnic groups, and individuals with and without
disabilities on its advisory committees and, therefore encourages
nominations of appropriately qualified candidates from these groups. A
nominee may either be self-nominated or nominated by an organization.
In addition, FDA is requesting that any industry organizations
interested in participating in the selection of a nonvoting
representative of the interests of the tobacco manufacturing industry
to serve on the TPSAC notify FDA in writing. Nominations will be
accepted for either the representative to serve on TPSAC or for the
selection group effective with this notice.
DATES: Nomination materials for prospective candidates should be sent
to FDA by November 18, 2019. Concurrently, any industry organization
interested in participating in the selection of an appropriate
nonvoting member to represent the interests of the tobacco
manufacturing industry must send a letter stating that interest to FDA
by November 18, 2019, (see sections I and II of this document for
further details).
ADDRESSES: All nominations for nonvoting representatives of the
interests of the tobacco manufacturing industry may be submitted
electronically by accessing the FDA Advisory Committee Membership
Nomination Portal at: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm, or by mail to Advisory Committee
Oversight and Management Staff, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993-0002.
All statements of interest from industry organizations interested
in participating in the selection process of nonvoting representatives
of the interests of the tobacco manufacturing industry nomination
should be sent to Janice O'Connor (see FOR FURTHER INFORMATION
CONTACT).
FOR FURTHER INFORMATION CONTACT: Janice O'Connor, Office of Science,
Center for Tobacco Products, Food and Drug Administration, Document
Control Center, 10903 New Hampshire Ave., Bldg. 71, Rm. G335, Silver
Spring, MD 20993-0002, 1-877-287-1373 (choose Option 5), email:
[email protected].
Information about becoming a member of an FDA advisory committee
can also be obtained by visiting FDA's website at: http://www.fda.gov/AdvisoryCommittees/default.htm.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for a
nonvoting representative of the interests of the tobacco manufacturing
industry on the Tobacco Products Scientific Advisory Committee (TPSAC).
I. General Description of the Committee Duties
The TPSAC advises the Commissioner of Food and Drugs (the
Commissioner) or designee in discharging responsibilities related to
the regulation of tobacco products. The TPSAC reviews and evaluates
safety, dependence, or health issues relating to tobacco products and
provides
[[Page 55576]]
appropriate advice, information, and recommendations to the
Commissioner.
II. Nomination Procedure
Individuals may self-nominate and/or an organization may nominate
one or more individuals to serve as a nonvoting representative of the
interests of the tobacco manufacturing industry. Nominations must
include a current r[eacute]sum[eacute] or curriculum vitae for each
nominee, including current business address and/or home address,
telephone number, and email address, if available. Nominations must
specify the advisory committee for which the nominee is recommended.
Nominations must also acknowledge that the nominee is aware of the
nomination unless self-nominated. The nomination should be sent to the
FDA Advisory Committee Membership Nomination Portal (see ADDRESSES)
within 30 days of publication of this document (see DATES). FDA will
forward all nominations to the organizations expressing interest in
participating in the selection process. (Persons who nominate
themselves as nonvoting industry representatives will not participate
in the selection process.)
III. Selection Procedure
The Agency is also seeking names of organizations to participate in
the selection of the nonvoting representative of the interests of the
tobacco manufacturing industry. Any industry organization interested in
participating in the selection of an appropriate nonvoting member to
represent industry interests should send a letter stating that interest
to the FDA contact (see FOR FURTHER INFORMATION CONTACT) within 30 days
of publication of this document (see DATES). Within the subsequent 30
days, FDA will send a letter to each organization that has expressed an
interest in participating in the selection group, attaching a complete
list of all organizations participating in selection; and a list of all
non-voting nominees along with their current r[eacute]sum[eacute]s. The
letter will also state that it is the responsibility of the interested
organizations on the selection group to confer with one another and to
select a candidate and an alternative as backup, within 60 days after
the receipt of the FDA letter, to serve as the nonvoting member to
represent industry interests for the TPSAC. The interested
organizations are not bound by the list of nominees in selecting a
candidate. However, if no individual is selected within 60 days, the
Commissioner will select the nonvoting member to represent industry
interests.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: October 10, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-22683 Filed 10-16-19; 8:45 am]
BILLING CODE 4164-01-P